histology

After Acquiring Italian Company, North Texas’ StatLab Launches Diapath Pathology Equipment

by | Sep 26, 2025
“When we acquired Diapath, our vision was clear: to expand access to the most innovative histology instrumentation worldwide,” StatLab CEO Dae Hong said.
MORE
North Texas’ StatLab Acquires 2 Pathology-Focused Companies in Germany and France
by | Aug 14, 2025
McKinney-based StatLab said the moves mark "a significant step forward" in its European growth strategy, expanding its direct commercial presence to the top four European markets: France, Germany, Italy, and the U.K.
MORE
North Texas-Based StatLab Expands European Presence With Acquisition of Italy’s Diapath
by | Aug 28, 2024
McKinney-based StatLab Medical Products is scaling its global reach with a series of strategic moves, including acquisitions and expanded facilities, such as a new one in Arlington. CEO Sung-Dae Hong, who took the helm this time last year, brings decades of experience in driving growth and M&A.
MORE
McKinney’s StatLab Medical Products Launches New Manufacturing Facility in Arlington
by | Feb 14, 2024
StatLab said its 2022 acquisition of Wales-based CellPath Ltd.—known for injection molding manufacturing of histology supplies—served as a catalyst for its new, 35,000-square-foot facility in Arlington.
MORE